Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cardiovascular Disease
100%
Cardiovascular Mortality
100%
Kidney Function
100%
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)
100%
Cystatin C (Cys C)
83%
β2-microglobulin (β2-MG)
83%
Kidney Failure
66%
Heart Failure
33%
Coronary Artery Disease
33%
Outcome Prediction
33%
C-level
33%
Atherosclerotic Risk Factors
16%
Serum Creatinine
16%
Population-based Study
16%
Serum Creatinine Level
16%
Risk Prediction
16%
Direct Measurement
16%
Albumin-to-creatinine Ratio
16%
Risk Estimation
16%
Heart-kidney
16%
Estimated Glomerular Filtration Rate
16%
Cystatin
16%
Reduced Kidney Function
16%
Outcome Mortality
16%
Additional Markers
16%
Current Estimation
16%
Observational Cohort Study
16%
Filtration Marker
16%
Renal Filtration
16%
Chronic Kidney Disease Epidemiology Collaboration Equation
16%
Medicine and Dentistry
Cardiovascular Disease
100%
End Stage Renal Disease
100%
Kidney Function
100%
Chronic Kidney Disease
100%
Cardiovascular Mortality
100%
Disease Epidemiology
100%
Cystatin C
71%
Renal Failure
57%
Creatinine
42%
Congestive Heart Failure
28%
Ischemic Heart Disease
28%
Atherosclerosis
14%
Glomerular Filtration Rate
14%
Urinary System
14%
Cohort Study
14%
Cystatin
14%
Trace Protein
14%
Albumin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
100%
End Stage Renal Disease
100%
Chronic Kidney Failure
100%
Cardiovascular Mortality
100%
Cystatin C
71%
Kidney Failure
57%
Creatinine
42%
Congestive Heart Failure
28%
Ischemic Heart Disease
28%
Atherosclerosis
14%
Cohort Study
14%
Cystatin
14%
Albumin
14%